| December 15, 2003 | ||||||||||
In Print![]() Photo by Graham Ramsay
From Focus: HMS researchers, working with scientists at other institutions, have identified a cellular receptor that enables the SARS virus to gain a foothold in the human body--a discovery that could open the door to drug and vaccine strategies for combating the infection. Michael Farzan and his colleagues found that they could slow SARS replication by exposing infected cells to antibodies against the receptor, ACE2. In a pinch, these same antibodies might be used to combat another SARS outbreak.
|
|
HeadlinesResearchers Shed Light on Myotonic Muscular Dystrophy Women Suffering from Severe Arthritis May Also Be at High Risk for Osteoporosis Mouse Embryonic Germ Cells and Male Gametes Created in the Lab Surgery Without Radiation Inadequate for Ductal Carcinoma In Situ Fertility Worries Common in Young Breast Cancer Survivors It's Never Too Late to Start Exercising and Losing Weight to Have a Healthier Cardiovascular System Good and Bad Fats Linked to Progression of Age-related Macular Degeneration One Combination of AIDS Drugs Appears Better for Starting Treatment Ritalin Use in Childhood May Increase Depression, Decrease Cocaine Sensitivity in Adults |
Spotlight
Student Scene
UpcomingMilestone Symposium Series:Stem Cells and Regenerative Medicine
Several presenters
Lab WorksA multimedia site featuring Harvard Medical research |
|||||||
Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home |